市場調査レポート

商品コード

1802941

NAD+IVクリニック市場の2032年までの予測：タイプ別、治療タイプ別、規制状況別、用途別、エンドユーザー別、地域別の世界分析

NAD+ IV Clinics Market Forecasts to 2032 - Global Analysis By Type, Therapy Type, Regulatory Status, Application, End User and By Geography

出版日: 2025年09月07日
発行: Stratistics Market Research Consulting
ページ情報: 英文 200+ Pages
納期: 2～3営業日

カスタマイズ可能

価格

PDF (Single User License)

USD 4,150 619,387円

レポートPDFを1名様のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は1回のみ可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (2-5 User License)

USD 5,250 783,562円

レポートPDFを同一事業所（所在地）内の5名までご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は5回まで可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF & Excel (Site License)

USD 6,350 947,737円

レポートPDFおよびExcelを同一事業所（所在地）内のすべての方にご利用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピーは可能です。PDFおよびExcelの印刷は5回まで可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

PDF & Excel (Global Site License)

USD 7,500 1,119,375円

レポートPDFおよびExcelを企業内すべての方に使用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピーは可能です。PDFおよびExcelの印刷は10回まで可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=149.25円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

Stratistics MRCによると、NAD+IVクリニックの世界市場は2025年に5億1,190万米ドルとなり、2032年までには10億4,945万米ドルに達すると予測され、予測期間中のCAGRは10.8％です。

NAD+IVクリニックは、ニコチンアミドアデニンジヌクレオチド（NAD+）の静脈内注入を提供する専門のウェルネスセンターです。NAD+IV療法は通常、細胞の健康を促進し、エネルギーを高め、精神を明瞭にし、疲労を軽減し、薬物乱用やストレスからの回復過程を助ける手段として、これらのクリニックで推進されています。さらに、NAD+は血流に直接投与されるため、この治療は経口サプリメントよりも吸収率が高いと考えられています。

IV NAD+ヒト試験研究によると、750mgのNAD+を6時間点滴した場合、血漿中のNAD+と主要代謝物は6時間後までにベースラインの約400％まで上昇し、尿中のNAD+排泄量は6時間後に約538％増加しました。

ウェルネスと長寿に対する需要の高まり

積極的なウェルネスと健康寿命の延長に対する世界的な強調は、NAD+IVクリニックの需要を促進する主な要因です。高齢化が進むにつれ、活力や精神力を維持し、加齢による衰えへの抵抗力を高める方法を求める人が増えています。NAD+療法は、活力を高め、細胞を修復し、目に見える老化のプロセスを遅らせる自然な手段として推進されています。NAD+療法は、集中力を高め、スタミナを増強し、回復を早めることから、若い消費者、特に健康愛好家やスポーツ選手にアピールしています。静脈内投与は、従来のサプリメントとは対照的に、即座に吸収されるため、プレミアムなオプションとして位置づけられています。

高額な治療費

治療費の高さは、NAD+IVクリニック市場にとって最大の障壁の一つです。投与量やクリニックの場所にもよりますが、1回のNAD+点滴にかかる費用は、数百ドルから数千ドルと幅があります。治療効果を長期間持続させるためには、数回のセッションが必要になることが多いため、一般的な消費者にとっては、費用はすぐに手の届かないものになってしまいます。このため、NAD+IV療法は、主に裕福な顧客が利用できる、高級または贅沢なウェルネスサービスとして位置づけられています。従来の栄養補助食品とは対照的に、保険が適用される頻度が低いため、手の届きやすさはさらに制限されます。

ホリスティック・ウェルネスのためのプログラムとの組み合わせ

NAD+IV療法をより大規模なウェルネスやライフスタイルの取り組みと統合することは、大きなチャンスです。クリニックは、点滴をストレス管理、フィットネストレーニング、栄養計画、バイオハッキングツールなどのサービスと組み合わせることで、ホリスティック・ウェルネス・パッケージを作成することができます。1回きりのサービスではなく、継続的な交流を促進することで、この統合は顧客維持を高めます。フィットネス施設、ヨガ・センター、ウェルネス・リトリートとのコラボレーションは、知名度を高め、新規顧客を惹きつけることができます。NAD+をホリスティック・プログラムの補完療法と位置づけることで、その認知価値が高まり、重点が贅沢品からライフスタイルの変革に移り、個別化された多面的な健康・ウェルネス・ソリューションを求める顧客を惹きつけることができます。

科学的反証または不十分な証明

NAD+IV療法が宣伝されているとおりの効果を、将来の科学的研究で確認できない可能性は、この治療の最大のリスクのひとつです。広範な調査によって、経口サプリメントやプラセボ治療と比較してほとんど効果がないことが明らかになれば、この治療法は信用を失う可能性があります。そのような発見があれば、消費者の懐疑的な見方や保険拒否、規制当局の取り締まりが強まると思われます。市場の大部分は逸話的な結果や初期段階の研究に依存しているため、弱い証拠は信頼を損なう危険性が高いです。さらに、NAD+IV療法に疑念を抱かせるような注目度の高い科学的研究が一つでもあれば、需要が大幅に減少し、業界の地位が損なわれ、診療所のさらなる投資が抑止される可能性があります。

COVID-19の影響：

COVID-19の大流行は、NAD+IVクリニック市場にさまざまな影響を与えました。渡航制限、ロックダウン、対面診療の減少により、選択的ウェルネス治療や診療所運営の需要が一時的に鈍化しました。不要不急のサービスを制限する規制や人通りの減少により、多数の小規模クリニックが閉鎖を余儀なくされました。しかし、パンデミックはまた、回復、免疫の健康、予防的ウェルネスに対する消費者の関心を高め、エネルギーサポートと細胞修復のためのNAD+IV療法などの新しい知識をもたらしました。人々が疲労、長く続くCOVID症状、一般的な回復力に対する治療法を求めていたため、パンデミック後に需要が急増しました。この2つの効果により、市場は免疫力向上と回復に重点を置いたウェルネス・モデルへとシフトしました。

予測期間中、NAD+混合ビタミン注射剤分野が最大となる見込み

NAD+混合ビタミン注射剤セグメントは、ビタミンCやB群などのサポートビタミンと適量のNAD+を組み合わせることで、より手頃な価格帯で幅広いウェルネス効果を提供するため、予測期間中に最大の市場シェアを占めると予想されます。純粋なNAD+や高濃度のNAD+点滴のような高いコストや強度を伴わずに、エネルギー増加、細胞修復、回復、免疫サポートといったバランスの取れた結果が得られるため、このセグメントは初めてのユーザーから健康志向の専門家まで幅広い顧客にアピールしています。さらに、混合ビタミン製剤はクリニックで提供される製品の大半を占めており、完全で適応性の高いソリューションを提供することから、消費者の間で最も人気のある選択肢であり続けています。

予測期間中、住宅用/家庭用が最も高いCAGRが見込まれる

予測期間中、オンデマンド医療サービス、個別化されたウェルネス、利便性へのニーズの高まりにより、住宅／家庭用セグメントが最も高い成長率を示すと予測されます。時間を節約し、通院を避け、自分のスケジュールに合わせて快適さを重視した治療を受けるために、消費者は自宅でNAD+輸液を受けることを選択するようになってきています。高所得者、多忙な専門家、慢性的な健康問題やCOVID後の疲労を抱える患者は、特にこのモデルを好んでいます。さらに、在宅NAD+療法は、モバイル点滴サービスプロバイダーやアプリベースの予約システムによって、従来のヘルスケア環境以外でのアクセスを拡大しながら、柔軟性とプライバシーを提供するため、最も高い成長率が予想される市場です。

最大のシェアを占める地域：

予測期間中、北米地域が最大の市場シェアを占めると予想されますが、その背景にはウェルネス分野の隆盛、予防ヘルスケアに関する消費者の高い意識、パフォーマンス向上、デトックス、アンチエイジングを目的とした治療に対する旺盛な需要があります。特に米国は、IV療法専門クリニックの数が多いこと、モバイル・ウェルネスやコンシェルジュ・サービスの利用が増加していること、最先端の医療を重視する文化があることから、市場をリードしています。さらに、北米の世界市場における優位性は、可処分所得の高さ、選択的ウェルネス治療を支持する規制の枠組み、NAD+療法のホリスティック・ヘルス・プログラムへの迅速な統合によってさらに裏付けられています。

CAGRが最も高い地域：

予測期間中、アジア太平洋が最も高いCAGRを示すと予測されます。これは、最先端のウェルネス治療やアンチエイジング治療に対する意識の高まり、急速な都市化、可処分所得の増加などが背景にあります。中国、日本、韓国、インドなどの国々では、ホリスティック療法や予防医療に対する需要が高まっています。この動向は、同地域の民間ウェルネス・センター・ネットワークの拡大や医療ツーリズム産業にも支えられています。さらに、アジア太平洋は、ライフスタイルの選択に関連したストレスや慢性疾患の増加に伴い、最先端でアクセスしやすい高品質のIV療法に対する需要が高まっており、最も成長率の高い地域となっています。

無料のカスタマイズサービス：

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます：

企業プロファイル
- 追加市場プレーヤーの包括的プロファイリング（3社まで）
- 主要企業のSWOT分析（3社まで）
地域セグメンテーション
- 顧客の関心に応じた主要国の市場推計・予測・CAGR（注：フィージビリティチェックによる）
競合ベンチマーキング
- 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

北米
- 米国
- カナダ
- メキシコ
欧州
- ドイツ
- 英国
- イタリア
- フランス
- スペイン
- その他欧州
アジア太平洋
- 日本
- 中国
- インド
- オーストラリア
- ニュージーランド
- 韓国
- その他アジア太平洋
南米
- アルゼンチン
- ブラジル
- チリ
- その他南米
中東・アフリカ
- サウジアラビア
- アラブ首長国連邦
- カタール
- 南アフリカ
- その他中東・アフリカ

第11章主な発展

契約、パートナーシップ、コラボレーション、ジョイントベンチャー
買収と合併
新製品発売
事業拡大
その他の主要戦略

第12章企業プロファイリング

Wellness Lab Inc
Mobile IV Medics Inc
Fika Infusion+Wellness
Azivmedics Inc
MD Infusions Inc
Premium Health
Conciergemdla Inc
Longevity Lab
Reset IV
Seaside Skin Care Inc
NADclinic
Emirates Hospitals（NAD+IV Therapy Division）
ALIV Therapy
The Hydration Room
The Elixir Clinic

図表

List of Tables

Table 1 Global NAD+ IV Clinics Market Outlook, By Region (2024-2032) ($MN)
Table 2 Global NAD+ IV Clinics Market Outlook, By Type (2024-2032) ($MN)
Table 3 Global NAD+ IV Clinics Market Outlook, By NAD+ Mixed Vitamin Injections (2024-2032) ($MN)
Table 4 Global NAD+ IV Clinics Market Outlook, By Pure NAD+ Injection (2024-2032) ($MN)
Table 5 Global NAD+ IV Clinics Market Outlook, By High-Concentration NAD+ Injection (2024-2032) ($MN)
Table 6 Global NAD+ IV Clinics Market Outlook, By Therapy Type (2024-2032) ($MN)
Table 7 Global NAD+ IV Clinics Market Outlook, By Standard NAD+ IV Therapy (2024-2032) ($MN)
Table 8 Global NAD+ IV Clinics Market Outlook, By Customized NAD+ IV Therapy (2024-2032) ($MN)
Table 9 Global NAD+ IV Clinics Market Outlook, By Adjunctive Therapies (2024-2032) ($MN)
Table 10 Global NAD+ IV Clinics Market Outlook, By Regulatory Status (2024-2032) ($MN)
Table 11 Global NAD+ IV Clinics Market Outlook, By Approved NAD+ Therapies (2024-2032) ($MN)
Table 12 Global NAD+ IV Clinics Market Outlook, By Experimental or Off-Label Use (2024-2032) ($MN)
Table 13 Global NAD+ IV Clinics Market Outlook, By Application (2024-2032) ($MN)
Table 14 Global NAD+ IV Clinics Market Outlook, By Clinics (2024-2032) ($MN)
Table 15 Global NAD+ IV Clinics Market Outlook, By Hospitals (2024-2032) ($MN)
Table 16 Global NAD+ IV Clinics Market Outlook, By Residential/Home Use (2024-2032) ($MN)
Table 17 Global NAD+ IV Clinics Market Outlook, By End User (2024-2032) ($MN)
Table 18 Global NAD+ IV Clinics Market Outlook, By Wellness Centers (2024-2032) ($MN)
Table 19 Global NAD+ IV Clinics Market Outlook, By Functional Medicine Practices (2024-2032) ($MN)
Table 20 Global NAD+ IV Clinics Market Outlook, By Mobile IV Services (2024-2032) ($MN)
Table 21 North America NAD+ IV Clinics Market Outlook, By Country (2024-2032) ($MN)
Table 22 North America NAD+ IV Clinics Market Outlook, By Type (2024-2032) ($MN)
Table 23 North America NAD+ IV Clinics Market Outlook, By NAD+ Mixed Vitamin Injections (2024-2032) ($MN)
Table 24 North America NAD+ IV Clinics Market Outlook, By Pure NAD+ Injection (2024-2032) ($MN)
Table 25 North America NAD+ IV Clinics Market Outlook, By High-Concentration NAD+ Injection (2024-2032) ($MN)
Table 26 North America NAD+ IV Clinics Market Outlook, By Therapy Type (2024-2032) ($MN)
Table 27 North America NAD+ IV Clinics Market Outlook, By Standard NAD+ IV Therapy (2024-2032) ($MN)
Table 28 North America NAD+ IV Clinics Market Outlook, By Customized NAD+ IV Therapy (2024-2032) ($MN)
Table 29 North America NAD+ IV Clinics Market Outlook, By Adjunctive Therapies (2024-2032) ($MN)
Table 30 North America NAD+ IV Clinics Market Outlook, By Regulatory Status (2024-2032) ($MN)
Table 31 North America NAD+ IV Clinics Market Outlook, By Approved NAD+ Therapies (2024-2032) ($MN)
Table 32 North America NAD+ IV Clinics Market Outlook, By Experimental or Off-Label Use (2024-2032) ($MN)
Table 33 North America NAD+ IV Clinics Market Outlook, By Application (2024-2032) ($MN)
Table 34 North America NAD+ IV Clinics Market Outlook, By Clinics (2024-2032) ($MN)
Table 35 North America NAD+ IV Clinics Market Outlook, By Hospitals (2024-2032) ($MN)
Table 36 North America NAD+ IV Clinics Market Outlook, By Residential/Home Use (2024-2032) ($MN)
Table 37 North America NAD+ IV Clinics Market Outlook, By End User (2024-2032) ($MN)
Table 38 North America NAD+ IV Clinics Market Outlook, By Wellness Centers (2024-2032) ($MN)
Table 39 North America NAD+ IV Clinics Market Outlook, By Functional Medicine Practices (2024-2032) ($MN)
Table 40 North America NAD+ IV Clinics Market Outlook, By Mobile IV Services (2024-2032) ($MN)
Table 41 Europe NAD+ IV Clinics Market Outlook, By Country (2024-2032) ($MN)
Table 42 Europe NAD+ IV Clinics Market Outlook, By Type (2024-2032) ($MN)
Table 43 Europe NAD+ IV Clinics Market Outlook, By NAD+ Mixed Vitamin Injections (2024-2032) ($MN)
Table 44 Europe NAD+ IV Clinics Market Outlook, By Pure NAD+ Injection (2024-2032) ($MN)
Table 45 Europe NAD+ IV Clinics Market Outlook, By High-Concentration NAD+ Injection (2024-2032) ($MN)
Table 46 Europe NAD+ IV Clinics Market Outlook, By Therapy Type (2024-2032) ($MN)
Table 47 Europe NAD+ IV Clinics Market Outlook, By Standard NAD+ IV Therapy (2024-2032) ($MN)
Table 48 Europe NAD+ IV Clinics Market Outlook, By Customized NAD+ IV Therapy (2024-2032) ($MN)
Table 49 Europe NAD+ IV Clinics Market Outlook, By Adjunctive Therapies (2024-2032) ($MN)
Table 50 Europe NAD+ IV Clinics Market Outlook, By Regulatory Status (2024-2032) ($MN)
Table 51 Europe NAD+ IV Clinics Market Outlook, By Approved NAD+ Therapies (2024-2032) ($MN)
Table 52 Europe NAD+ IV Clinics Market Outlook, By Experimental or Off-Label Use (2024-2032) ($MN)
Table 53 Europe NAD+ IV Clinics Market Outlook, By Application (2024-2032) ($MN)
Table 54 Europe NAD+ IV Clinics Market Outlook, By Clinics (2024-2032) ($MN)
Table 55 Europe NAD+ IV Clinics Market Outlook, By Hospitals (2024-2032) ($MN)
Table 56 Europe NAD+ IV Clinics Market Outlook, By Residential/Home Use (2024-2032) ($MN)
Table 57 Europe NAD+ IV Clinics Market Outlook, By End User (2024-2032) ($MN)
Table 58 Europe NAD+ IV Clinics Market Outlook, By Wellness Centers (2024-2032) ($MN)
Table 59 Europe NAD+ IV Clinics Market Outlook, By Functional Medicine Practices (2024-2032) ($MN)
Table 60 Europe NAD+ IV Clinics Market Outlook, By Mobile IV Services (2024-2032) ($MN)
Table 61 Asia Pacific NAD+ IV Clinics Market Outlook, By Country (2024-2032) ($MN)
Table 62 Asia Pacific NAD+ IV Clinics Market Outlook, By Type (2024-2032) ($MN)
Table 63 Asia Pacific NAD+ IV Clinics Market Outlook, By NAD+ Mixed Vitamin Injections (2024-2032) ($MN)
Table 64 Asia Pacific NAD+ IV Clinics Market Outlook, By Pure NAD+ Injection (2024-2032) ($MN)
Table 65 Asia Pacific NAD+ IV Clinics Market Outlook, By High-Concentration NAD+ Injection (2024-2032) ($MN)
Table 66 Asia Pacific NAD+ IV Clinics Market Outlook, By Therapy Type (2024-2032) ($MN)
Table 67 Asia Pacific NAD+ IV Clinics Market Outlook, By Standard NAD+ IV Therapy (2024-2032) ($MN)
Table 68 Asia Pacific NAD+ IV Clinics Market Outlook, By Customized NAD+ IV Therapy (2024-2032) ($MN)
Table 69 Asia Pacific NAD+ IV Clinics Market Outlook, By Adjunctive Therapies (2024-2032) ($MN)
Table 70 Asia Pacific NAD+ IV Clinics Market Outlook, By Regulatory Status (2024-2032) ($MN)
Table 71 Asia Pacific NAD+ IV Clinics Market Outlook, By Approved NAD+ Therapies (2024-2032) ($MN)
Table 72 Asia Pacific NAD+ IV Clinics Market Outlook, By Experimental or Off-Label Use (2024-2032) ($MN)
Table 73 Asia Pacific NAD+ IV Clinics Market Outlook, By Application (2024-2032) ($MN)
Table 74 Asia Pacific NAD+ IV Clinics Market Outlook, By Clinics (2024-2032) ($MN)
Table 75 Asia Pacific NAD+ IV Clinics Market Outlook, By Hospitals (2024-2032) ($MN)
Table 76 Asia Pacific NAD+ IV Clinics Market Outlook, By Residential/Home Use (2024-2032) ($MN)
Table 77 Asia Pacific NAD+ IV Clinics Market Outlook, By End User (2024-2032) ($MN)
Table 78 Asia Pacific NAD+ IV Clinics Market Outlook, By Wellness Centers (2024-2032) ($MN)
Table 79 Asia Pacific NAD+ IV Clinics Market Outlook, By Functional Medicine Practices (2024-2032) ($MN)
Table 80 Asia Pacific NAD+ IV Clinics Market Outlook, By Mobile IV Services (2024-2032) ($MN)
Table 81 South America NAD+ IV Clinics Market Outlook, By Country (2024-2032) ($MN)
Table 82 South America NAD+ IV Clinics Market Outlook, By Type (2024-2032) ($MN)
Table 83 South America NAD+ IV Clinics Market Outlook, By NAD+ Mixed Vitamin Injections (2024-2032) ($MN)
Table 84 South America NAD+ IV Clinics Market Outlook, By Pure NAD+ Injection (2024-2032) ($MN)
Table 85 South America NAD+ IV Clinics Market Outlook, By High-Concentration NAD+ Injection (2024-2032) ($MN)
Table 86 South America NAD+ IV Clinics Market Outlook, By Therapy Type (2024-2032) ($MN)
Table 87 South America NAD+ IV Clinics Market Outlook, By Standard NAD+ IV Therapy (2024-2032) ($MN)
Table 88 South America NAD+ IV Clinics Market Outlook, By Customized NAD+ IV Therapy (2024-2032) ($MN)
Table 89 South America NAD+ IV Clinics Market Outlook, By Adjunctive Therapies (2024-2032) ($MN)
Table 90 South America NAD+ IV Clinics Market Outlook, By Regulatory Status (2024-2032) ($MN)
Table 91 South America NAD+ IV Clinics Market Outlook, By Approved NAD+ Therapies (2024-2032) ($MN)
Table 92 South America NAD+ IV Clinics Market Outlook, By Experimental or Off-Label Use (2024-2032) ($MN)
Table 93 South America NAD+ IV Clinics Market Outlook, By Application (2024-2032) ($MN)
Table 94 South America NAD+ IV Clinics Market Outlook, By Clinics (2024-2032) ($MN)
Table 95 South America NAD+ IV Clinics Market Outlook, By Hospitals (2024-2032) ($MN)
Table 96 South America NAD+ IV Clinics Market Outlook, By Residential/Home Use (2024-2032) ($MN)
Table 97 South America NAD+ IV Clinics Market Outlook, By End User (2024-2032) ($MN)
Table 98 South America NAD+ IV Clinics Market Outlook, By Wellness Centers (2024-2032) ($MN)
Table 99 South America NAD+ IV Clinics Market Outlook, By Functional Medicine Practices (2024-2032) ($MN)
Table 100 South America NAD+ IV Clinics Market Outlook, By Mobile IV Services (2024-2032) ($MN)
Table 101 Middle East & Africa NAD+ IV Clinics Market Outlook, By Country (2024-2032) ($MN)
Table 102 Middle East & Africa NAD+ IV Clinics Market Outlook, By Type (2024-2032) ($MN)
Table 103 Middle East & Africa NAD+ IV Clinics Market Outlook, By NAD+ Mixed Vitamin Injections (2024-2032) ($MN)
Table 104 Middle East & Africa NAD+ IV Clinics Market Outlook, By Pure NAD+ Injection (2024-2032) ($MN)
Table 105 Middle East & Africa NAD+ IV Clinics Market Outlook, By High-Concentration NAD+ Injection (2024-2032) ($MN)
Table 106 Middle East & Africa NAD+ IV Clinics Market Outlook, By Therapy Type (2024-2032) ($MN)
Table 107 Middle East & Africa NAD+ IV Clinics Market Outlook, By Standard NAD+ IV Therapy (2024-2032) ($MN)
Table 108 Middle East & Africa NAD+ IV Clinics Market Outlook, By Customized NAD+ IV Therapy (2024-2032) ($MN)
Table 109 Middle East & Africa NAD+ IV Clinics Market Outlook, By Adjunctive Therapies (2024-2032) ($MN)
Table 110 Middle East & Africa NAD+ IV Clinics Market Outlook, By Regulatory Status (2024-2032) ($MN)
Table 111 Middle East & Africa NAD+ IV Clinics Market Outlook, By Approved NAD+ Therapies (2024-2032) ($MN)
Table 112 Middle East & Africa NAD+ IV Clinics Market Outlook, By Experimental or Off-Label Use (2024-2032) ($MN)
Table 113 Middle East & Africa NAD+ IV Clinics Market Outlook, By Application (2024-2032) ($MN)
Table 114 Middle East & Africa NAD+ IV Clinics Market Outlook, By Clinics (2024-2032) ($MN)
Table 115 Middle East & Africa NAD+ IV Clinics Market Outlook, By Hospitals (2024-2032) ($MN)
Table 116 Middle East & Africa NAD+ IV Clinics Market Outlook, By Residential/Home Use (2024-2032) ($MN)
Table 117 Middle East & Africa NAD+ IV Clinics Market Outlook, By End User (2024-2032) ($MN)
Table 118 Middle East & Africa NAD+ IV Clinics Market Outlook, By Wellness Centers (2024-2032) ($MN)
Table 119 Middle East & Africa NAD+ IV Clinics Market Outlook, By Functional Medicine Practices (2024-2032) ($MN)
Table 120 Middle East & Africa NAD+ IV Clinics Market Outlook, By Mobile IV Services (2024-2032) ($MN)

Product Code: SMRC30467

According to Stratistics MRC, the Global NAD+ IV Clinics Market is accounted for $511.90 million in 2025 and is expected to reach $1049.45 million by 2032 growing at a CAGR of 10.8% during the forecast period. NAD+ IV clinics are specialized wellness centers that provide intravenous infusions of nicotinamide adenine dinucleotide (NAD+), a coenzyme naturally found in the body that plays a critical role in cellular energy production and repair. NAD+ IV therapy is usually promoted by these clinics as a means of promoting cellular health, boosting energy, improving mental clarity, lowering fatigue, and aiding in the healing process from substance abuse or stress. Moreover, the treatment is thought to have a higher absorption rate than oral supplements because NAD+ is given straight into the bloodstream.

According to a human pilot study of IV NAD+ infusion, during a 6-hour 750 mg NAD+ intravenous drip, plasma NAD+ and key metabolites rose to ~400% of baseline by hour 6, urinary NAD+ excretion increased ~538% at 6 hours, and no serious adverse events were observed in the small cohort.

Market Dynamics:

Driver:

Increasing demand for wellness & longevity

The worldwide emphasis on proactive wellness and healthspan extension is a major factor driving the demand for NAD+ IV clinics. More and more people are looking for ways to preserve their vitality, mental acuity, and resistance to age-related decline as populations get older. NAD+ therapy is promoted as a natural means of increasing vitality, repairing cells, and delaying the observable aging process. The therapy appeals to younger consumers, particularly wellness enthusiasts and athletes, because it promotes better focus, increased stamina, and a quicker recovery. IV delivery is positioned as a premium option because it provides immediate absorption, in contrast to traditional supplements.

Restraint:

High treatment costs

The high cost of therapy is one of the biggest barriers to the market for NAD+ IV clinics. Depending on the dosage and clinic location, the cost of a single NAD+ infusion session can vary from a few hundred to several thousand dollars. Costs soon become unaffordable for typical consumers because treatments frequently call for several sessions to produce long-lasting effects. This presents NAD+ IV therapy as a high-end or luxury wellness service that is primarily available to wealthy customers. Its infrequent insurance coverage, in contrast to that of conventional nutritional supplements, further restricts affordability.

Opportunity:

Combining with Programs for Holistic Wellness

Integrating NAD+ IV therapy with larger wellness and lifestyle initiatives presents a significant opportunity. Clinics can create holistic wellness packages by combining infusions with services like stress management, fitness training, nutrition planning, and biohacking tools. By promoting ongoing interaction as opposed to one-time services, this integration increases customer retention. Collaborations with fitness facilities, yoga centers, and wellness retreats can increase visibility and attract new customers. By positioning NAD+ as a complementary therapy in holistic programs, its perceived value is increased, the emphasis is shifted from luxury to lifestyle transformation, and it attracts customers looking for individualized, multifaceted health and wellness solutions.

Threat:

Scientific rebuttal or insufficient proof

The potential for future scientific studies to fail to confirm the benefits of NAD+ IV therapy as advertised is one of the biggest risks to the treatment. The therapy may lose credibility if extensive research reveals little to no benefit when compared to oral supplements or placebo treatments. Such discoveries would increase consumer skepticism, insurance rejection, and regulatory crackdowns. Weak evidence has a high risk of undermining confidence because a large portion of the market depends on anecdotal results and early-stage research. Moreover, a single high-profile scientific study that casts doubt on NAD+ IV therapy could significantly reduce demand, harming the industry's standing and deterring further clinic investment.

Covid-19 Impact:

The COVID-19 pandemic affected the market for NAD+ IV clinics in a variety of ways. Travel restrictions, lockdowns, and fewer in-person medical visits momentarily slowed the demand for elective wellness treatments and clinic operations. Regulations restricting non-essential services and dwindling foot traffic forced the closure of numerous small clinics. However, the pandemic also increased consumer interest in recovery, immune health, and preventive wellness, bringing new knowledge of therapies such as NAD+ IV for energy support and cellular repair. As people looked for remedies for fatigue, long-lasting COVID symptoms, and general resilience, demand sharply increased after the pandemic. The market shifted toward wellness models that emphasize immunity-boosting and recovery as a result of these two effects.

The NAD+ mixed vitamin injections segment is expected to be the largest during the forecast period

The NAD+ mixed vitamin injections segment is expected to account for the largest market share during the forecast period because they offer broader wellness benefits at a more affordable price point by combining supportive vitamins like vitamin C and B-complex with moderate doses of NAD+. Because it provides balanced results like increased energy, cellular repair, recovery, and immune support without the higher costs or intensity of pure or high-concentration NAD+ infusions, this segment appeals to a wide range of clients, from first-time users to health-conscious professionals. Moreover, mixed vitamin formulations dominate clinic offerings and continue to be the most popular choice among consumers because they offer a complete, adaptable solution.

The residential/home use segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the residential/home use segment is predicted to witness the highest growth rate, driven by the growing need for on-demand medical services, personalized wellness, and convenience. In order to save time, avoid clinical visits, and receive comfort-focused treatments that fit their schedules, consumers are increasingly choosing to receive NAD+ infusions at home. High earners, busy professionals, and patients dealing with chronic wellness issues or post-COVID fatigue are particularly fond of this model. Additionally, home-based NAD+ therapy is the market with the highest anticipated growth rate because it provides flexibility and privacy while extending access outside of conventional healthcare settings, aided by mobile IV service providers and app-based booking systems.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, backed by a thriving wellness sector, a high level of consumer awareness regarding preventive healthcare, and a robust demand for treatments that improve performance, detox, and anti-aging. In particular, the United States leads because of the large number of specialized IV therapy clinics, the increasing use of mobile wellness and concierge services, and a culture that values cutting-edge medical advancements. Furthermore, North America's dominance in the global market is further supported by higher disposable incomes, regulatory frameworks that are supportive of elective wellness treatments, and the quick integration of NAD+ therapy into holistic health programs.

Region with highest CAGR:

Over the forecast period, the Asia-Pacific region is anticipated to exhibit the highest CAGR, driven by growing awareness of cutting-edge wellness and anti-aging treatments, fast urbanization, and rising disposable incomes. The demand for holistic therapies and preventive healthcare is rising in nations like China, Japan, South Korea, and India as working professionals and younger populations look for recovery-focused and energy-boosting solutions. This trend is further supported by the region's growing network of private wellness centers and medical tourism industry. Moreover, Asia-Pacific's demand for cutting-edge, easily accessible, and high-quality IV therapies makes it the region with the fastest rate of growth as stress and chronic illnesses linked to lifestyle choices increase.

Key players in the market

Some of the key players in NAD+ IV Clinics Market include Wellness Lab Inc, Mobile IV Medics Inc, Fika Infusion + Wellness, Azivmedics Inc, MD Infusions Inc, Premium Health, Conciergemdla Inc, Longevity Lab, Reset IV, Seaside Skin Care Inc, NADclinic, Emirates Hospitals (NAD+ IV Therapy Division), ALIV Therapy, The Hydration Room and The Elixir Clinic.

Key Developments:

In June 2025, Hydration Room proudly announces the opening of its newest clinic at Victoria Gardens in Rancho Cucamonga marking its first location in San Bernardino County. This opening marks the next step in Hydration Room's statewide expansion, with multiple Bay Area clinics launching later this summer.

In March 2025, Longevity solution provider NADclinic has partnered with Intuisse, which creates NAD+ skincare. The partnership will see both brands offering science-backed Nicotinamide Adenine Dinucleotide+ (NAD+) beauty products and wellness solutions across their ecommerce platforms. In a strategic collaboration, each brand will retail the other's products to improve accessibility to advanced NAD+ therapies.

Types Covered:

NAD+ Mixed Vitamin Injections
Pure NAD+ Injection
High-Concentration NAD+ Injection

Therapy Types Covered:

Standard NAD+ IV Therapy
Customized NAD+ IV Therapy
Adjunctive Therapies

Regulatory Status Covered:

Approved NAD+ Therapies
Experimental or Off-Label Use

Applications Covered:

Clinics
Hospitals
Residential/Home Use

End Users Covered:

Wellness Centers
Functional Medicine Practices
Mobile IV Services

Regions Covered:

North America
- US
- Canada
- Mexico
Europe
- Germany
- UK
- Italy
- France
- Spain
- Rest of Europe
Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- South Korea
- Rest of Asia Pacific
South America
- Argentina
- Brazil
- Chile
- Rest of South America
Middle East & Africa
- Saudi Arabia
- UAE
- Qatar
- South Africa
- Rest of Middle East & Africa

What our report offers:

Market share assessments for the regional and country-level segments
Strategic recommendations for the new entrants
Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments
Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

1 Executive Summary

2 Preface

2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
- 2.4.1 Data Mining
- 2.4.2 Data Analysis
- 2.4.3 Data Validation
- 2.4.4 Research Approach
2.5 Research Sources
- 2.5.1 Primary Research Sources
- 2.5.2 Secondary Research Sources
- 2.5.3 Assumptions

3 Market Trend Analysis

3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19

4 Porters Five Force Analysis

4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global NAD+ IV Clinics Market, By Type

5.1 Introduction
5.2 NAD+ Mixed Vitamin Injections
5.3 Pure NAD+ Injection
5.4 High-Concentration NAD+ Injection

6 Global NAD+ IV Clinics Market, By Therapy Type

6.1 Introduction
6.2 Standard NAD+ IV Therapy
6.3 Customized NAD+ IV Therapy
6.4 Adjunctive Therapies

7 Global NAD+ IV Clinics Market, By Regulatory Status

7.1 Introduction
7.2 Approved NAD+ Therapies
7.3 Experimental or Off-Label Use

8 Global NAD+ IV Clinics Market, By Application

8.1 Introduction
8.2 Clinics
8.3 Hospitals
8.4 Residential/Home Use

9 Global NAD+ IV Clinics Market, By End User

9.1 Introduction
9.2 Wellness Centers
9.3 Functional Medicine Practices
9.4 Mobile IV Services

10 Global NAD+ IV Clinics Market, By Geography

10.1 Introduction
10.2 North America
- 10.2.1 US
- 10.2.2 Canada
- 10.2.3 Mexico
10.3 Europe
- 10.3.1 Germany
- 10.3.2 UK
- 10.3.3 Italy
- 10.3.4 France
- 10.3.5 Spain
- 10.3.6 Rest of Europe
10.4 Asia Pacific
- 10.4.1 Japan
- 10.4.2 China
- 10.4.3 India
- 10.4.4 Australia
- 10.4.5 New Zealand
- 10.4.6 South Korea
- 10.4.7 Rest of Asia Pacific
10.5 South America
- 10.5.1 Argentina
- 10.5.2 Brazil
- 10.5.3 Chile
- 10.5.4 Rest of South America
10.6 Middle East & Africa
- 10.6.1 Saudi Arabia
- 10.6.2 UAE
- 10.6.3 Qatar
- 10.6.4 South Africa
- 10.6.5 Rest of Middle East & Africa

11 Key Developments

11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies

12 Company Profiling

12.1 Wellness Lab Inc
12.2 Mobile IV Medics Inc
12.3 Fika Infusion + Wellness
12.4 Azivmedics Inc
12.5 MD Infusions Inc
12.6 Premium Health
12.7 Conciergemdla Inc
12.8 Longevity Lab
12.9 Reset IV
12.10 Seaside Skin Care Inc
12.11 NADclinic
12.12 Emirates Hospitals (NAD+ IV Therapy Division)
12.13 ALIV Therapy
12.14 The Hydration Room
12.15 The Elixir Clinic

NAD+IVクリニック市場の2032年までの予測：タイプ別、治療タイプ別、規制状況別、用途別、エンドユーザー別、地域別の世界分析

NAD+ IV Clinics Market Forecasts to 2032 - Global Analysis By Type, Therapy Type, Regulatory Status, Application, End User and By Geography

COVID-19の影響：

最大のシェアを占める地域：

CAGRが最も高い地域：

無料のカスタマイズサービス：

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます：

目次

第1章 エグゼクティブサマリー

第2章 序文

第3章 市場動向分析

第4章 ポーターのファイブフォース分析

第5章 世界のNAD+IVクリニック市場：タイプ別

第6章 世界のNAD+IVクリニック市場：治療タイプ別

第7章 世界のNAD+IVクリニック市場：規制状況別

第8章 世界のNAD+IVクリニック市場：用途別

第9章 世界のNAD+IVクリニック市場：エンドユーザー別

第10章 世界のNAD+IVクリニック市場：地域別

第11章 主な発展

第12章 企業プロファイリング